RM.7.1.15

Heparinas de bajo peso molecular: usos clínicos
12. Kujouch J, Cassileth P: Decision making in
Medicine: Low-Molecular-Weight Heparine: More
indications for use. Hospital practice.
13. Levine M, et al: A comparison of Low-Molecular-
Weight Heparin administered primarily at home
with unfractionated heparin administered in the
hospital for proximal deep-vein thrombosis. N Engl
JM 334 (11): 677-681, 1996
14. Litin S, Heit J, Mees K: Use of low Molecular
Weight Heparin in the treatment of venous
thromboembolic disease: answers to frequently
asked questions. Mayo Clin Proc 73: 545-551, 1998
15. Mark D, et al: Economic assesment of HBPM
Enoxaparin versus unfractionates Heparin in acute
coronary Syndrome Patients. Circulation 97: 1702-
1707, 1998
16. Promes S, et al: Low-Molecular-Weight Heparins
in emergengy practice: guidelines and protocols for
thrombosis management acute ischemic syndromes
and deep venous thrombosis. Emergency Medicine
Reports. Hot topics in Healthcare.
17. Quader M, Stump L, Sumpio B: Low Molecular
Weight Heparins: Current use and Indications. J
Am Coll Surg 187 (6): 641-656, 1998
18. Sammama, et al: A comparison of enoxaparin with
placebo for the prevention of venous
thromboembolisis in acutely ill medical patients. N
Engl J M 334 (11): 793-799, 1999
19. Schulman S, et al: The duration of oral
anticoagulant therapy after a second episode of
venous thromboembolism. N Engl J M 336 (6):
393-397, 1997
20. Serra M, Jovell A, Aymerich M: Eficacia y
seguridad del tratamiento trombolítico en la
tromboembolia pulmonar: metanálisis de ensayos
controlados y aleatorizados. Medicina clínica 112
(18): 685-688, 1999
21. Simonneau G, et al: A comparison of Low-
Molecular-Weight Heparins with unfractionated
heparin for acute pulmonary embolism. N Engl J
Med 337 (10): 663-669, 1997
22. The Columbus Investigators: Low-Molecular-
Weigth Heparins in the treatment of patients with
venous thromboembolism. N Engl J Med 337 (10):
657-661, 1997
23. Verstraete M, Colin P, Samama M, Verhaeghe R: A
european view on the North American Fifth
Consensus on antithrombotic therapy. Chest
117(6): 1755-1767, 2000
24. Wallentin L, et al: Heparina de bajo peso molecular
en la inestabilización de la arteriopatía coronaria:
estudio multicéntrico aleatorio FRIS II. The Lancet
35 (6): 307-313, 1999
25. Warkenting T, et al: Heparin induced
thrombocytopenia in patients treated whit Low
Molecular Weight Heparin or unfractionated
Heparin. N Eng J M 332 (20): 1330-1335, 1995
26. Wood A: Low-Molecular- Weight Heparins. N
Engl J Med 337 (10): 688-696, 1997
Dr. Jaysoom Abarca Ruíz
Teléfono: (593) (04) 2435725
99